2017 Q3 Form 10-Q Financial Statement

#000088250817000033 Filed on August 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $3.026M $2.717M
YoY Change 11.37% -35.22%
Cost Of Revenue $1.646M $1.941M
YoY Change -15.2% -34.25%
Gross Profit $1.380M $776.0K
YoY Change 77.84% -37.52%
Gross Profit Margin 45.6% 28.56%
Selling, General & Admin $2.614M $2.591M
YoY Change 0.89% 3.31%
% of Gross Profit 189.42% 333.89%
Research & Development $2.319M $3.683M
YoY Change -37.04% -0.03%
% of Gross Profit 168.04% 474.61%
Depreciation & Amortization $350.0K $320.0K
YoY Change 9.38% -8.57%
% of Gross Profit 25.36% 41.24%
Operating Expenses $4.933M $6.274M
YoY Change -21.37% 0.08%
Operating Profit -$3.553M -$5.498M
YoY Change -35.38% 9.37%
Interest Expense $21.00K $34.00K
YoY Change -38.24% -2.86%
% of Operating Profit
Other Income/Expense, Net $1.000K -$15.00K
YoY Change -106.67% -61.54%
Pretax Income -$3.573M -$5.547M
YoY Change -35.59% 8.74%
Income Tax $34.00K $27.00K
% Of Pretax Income
Net Earnings -$3.607M -$5.574M
YoY Change -35.29% 9.59%
Net Earnings / Revenue -119.2% -205.15%
Basic Earnings Per Share -$0.05 -$0.08
Diluted Earnings Per Share -$0.05 -$0.08
COMMON SHARES
Basic Shares Outstanding 79.80M shares 67.42M shares
Diluted Shares Outstanding 79.80M shares 67.42M shares

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.20M $19.00M
YoY Change 16.84% -18.8%
Cash & Equivalents $22.23M $18.97M
Short-Term Investments
Other Short-Term Assets $125.0K $119.0K
YoY Change 5.04% 0.0%
Inventory $3.322M $2.318M
Prepaid Expenses $743.0K $864.0K
Receivables $1.051M $1.485M
Other Receivables $0.00 $0.00
Total Short-Term Assets $27.48M $23.76M
YoY Change 15.65% -15.99%
LONG-TERM ASSETS
Property, Plant & Equipment $2.529M $3.090M
YoY Change -18.16% 20.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $236.0K $307.0K
YoY Change -23.13% 32.9%
Total Long-Term Assets $2.765M $3.397M
YoY Change -18.6% 21.58%
TOTAL ASSETS
Total Short-Term Assets $27.48M $23.76M
Total Long-Term Assets $2.765M $3.397M
Total Assets $30.24M $27.15M
YoY Change 11.37% -12.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.200M $1.500M
YoY Change -20.0% -50.0%
Accrued Expenses $1.648M $1.434M
YoY Change 14.92% -29.32%
Deferred Revenue
YoY Change
Short-Term Debt $6.000M $0.00
YoY Change
Long-Term Debt Due $200.0K $100.0K
YoY Change 100.0% -50.0%
Total Short-Term Liabilities $9.121M $3.113M
YoY Change 193.0% -41.92%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $4.100M
YoY Change -97.56% 272.73%
Other Long-Term Liabilities $35.00K $120.0K
YoY Change -70.83% -5.51%
Total Long-Term Liabilities $35.00K $120.0K
YoY Change -70.83% -5.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.121M $3.113M
Total Long-Term Liabilities $35.00K $120.0K
Total Liabilities $9.285M $7.342M
YoY Change 26.46% 11.12%
SHAREHOLDERS EQUITY
Retained Earnings -$247.1M -$231.4M
YoY Change 6.76% 7.18%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.96M $19.81M
YoY Change
Total Liabilities & Shareholders Equity $30.24M $27.15M
YoY Change 11.37% -12.62%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income -$3.607M -$5.574M
YoY Change -35.29% 9.59%
Depreciation, Depletion And Amortization $350.0K $320.0K
YoY Change 9.38% -8.57%
Cash From Operating Activities -$3.890M -$5.100M
YoY Change -23.73% 82.8%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K -$460.0K
YoY Change -93.48% 475.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$30.00K -$460.0K
YoY Change -93.48% 475.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -520.0K 1.240M
YoY Change -141.94% -1227.27%
NET CHANGE
Cash From Operating Activities -3.890M -5.100M
Cash From Investing Activities -30.00K -460.0K
Cash From Financing Activities -520.0K 1.240M
Net Change In Cash -4.440M -4.320M
YoY Change 2.78% 44.97%
FREE CASH FLOW
Cash From Operating Activities -$3.890M -$5.100M
Capital Expenditures -$30.00K -$460.0K
Free Cash Flow -$3.860M -$4.640M
YoY Change -16.81% 71.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-07-02
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000882508
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
80111394 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
QUICKLOGIC CORPORATION
quik Purchase Of Equipment Included In Accounts Payable
PurchaseOfEquipmentIncludedInAccountsPayable
8000 USD
quik Purchase Of Equipment Included In Accounts Payable
PurchaseOfEquipmentIncludedInAccountsPayable
208000 USD
CY2017Q1 quik Shelf Registration Maximum Offering
ShelfRegistrationMaximumOffering
40000000.0 USD
CY2017Q1 quik Shelf Registration Numberof Offerings
ShelfRegistrationNumberofOfferings
1 offering
CY2017Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2018000 USD
CY2017Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1227000 USD
CY2017Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
839000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1051000 USD
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1580000 USD
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1648000 USD
CY2017Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12132000 USD
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12598000 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
251824000 USD
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
267951000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
439000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1001000 USD
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
347000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
665000 USD
CY2017Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
312000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2017Q1 us-gaap Assets
Assets
21844000 USD
CY2017Q3 us-gaap Assets
Assets
30240000 USD
CY2017Q1 us-gaap Assets Current
AssetsCurrent
18849000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
27475000 USD
CY2017Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
209000 USD
CY2017Q3 us-gaap Capital Lease Obligations
CapitalLeaseObligations
296000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14870000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22234000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-166000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7364000 USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
209000 USD
CY2017Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
167000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
251000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
296000 USD
CY2017Q1 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
0 USD
CY2017Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
129000 USD
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Executory Costs
CapitalLeasesFutureMinimumPaymentsExecutoryCosts
26000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19136000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18970000 USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68134000 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80103000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
68134000 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80103000 shares
CY2017Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
68000 USD
CY2017Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
80000 USD
CY2016Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1941000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3735000 USD
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1646000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3443000 USD
CY2017Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6209000 USD
CY2017Q3 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
6296000 USD
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
79000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
631000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
709000 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2017Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1222000 USD
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1252000 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2017Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
305000 USD
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
361000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
776000 USD
us-gaap Gross Profit
GrossProfit
1932000 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
1380000 USD
us-gaap Gross Profit
GrossProfit
2753000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5547000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10576000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3573000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7102000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
91000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
70000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
70000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1816000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-846000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-116000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
212000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-43000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
73000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
79000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-325000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1409000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-357000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-265000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-13000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-14000 USD
CY2016Q3 us-gaap Interest Expense
InterestExpense
34000 USD
us-gaap Interest Expense
InterestExpense
72000 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
21000 USD
us-gaap Interest Expense
InterestExpense
82000 USD
CY2017Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
479000 USD
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
968000 USD
CY2017Q1 us-gaap Inventory Net
InventoryNet
2017000 USD
CY2017Q3 us-gaap Inventory Net
InventoryNet
3322000 USD
CY2017Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1538000 USD
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2354000 USD
us-gaap Inventory Write Down
InventoryWriteDown
235000 USD
us-gaap Inventory Write Down
InventoryWriteDown
104000 USD
CY2017Q1 us-gaap Liabilities
Liabilities
9856000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
9285000 USD
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21844000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30240000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
9807000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9121000 USD
CY2017Q1 us-gaap Line Of Credit
LineOfCredit
6000000 USD
CY2017Q3 us-gaap Line Of Credit
LineOfCredit
6000000 USD
CY2017Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6000000 USD
CY2017Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6000000 USD
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
0 USD
CY2017Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
129000 USD
CY2017Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6209000 USD
CY2017Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
6167000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10909000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15170000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1513000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9562000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7758000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-5574000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10667000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3607000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7172000 USD
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
6274000 USD
us-gaap Operating Expenses
OperatingExpenses
12414000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
4933000 USD
us-gaap Operating Expenses
OperatingExpenses
9774000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5498000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10482000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3553000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7021000 USD
CY2016Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
206000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
404000 USD
CY2017Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
210000 USD
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
421000 USD
CY2017Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
358000 USD
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
396000 USD
CY2017Q1 us-gaap Other Assets Current
OtherAssetsCurrent
163000 USD
CY2017Q3 us-gaap Other Assets Current
OtherAssetsCurrent
125000 USD
CY2017Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
236000 USD
CY2017Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
49000 USD
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
35000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-22000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1197000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1771000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
103000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
64000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1513000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48000 USD
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1123000 USD
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
868000 USD
CY2017Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
960000 USD
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
743000 USD
CY2016Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8800000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15800000 USD
CY2017Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15800000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10447000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17304000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
2000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
6000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
70000 USD
CY2017Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14897000 USD
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15127000 USD
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2765000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2529000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
238000 USD
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
299000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
6000000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3683000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7130000 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2319000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4746000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239904000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-247076000 USD
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
2717000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
5667000 USD
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
3026000 USD
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79799000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74327000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
67415000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62893000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
1001000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
6196000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
665000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
107000 shares
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2591000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5284000 USD
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2614000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5028000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
378000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.57
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1370000 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1358000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.68
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
283000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.31
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3968000 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
97000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
117000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
656000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4979000 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4809000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.35
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.35
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
560000 USD
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4636000 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.39
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.31
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.96
CY2017Q3 us-gaap Share Price
SharePrice
1.46
CY2016Q1 us-gaap Share Price
SharePrice
1.00
CY2017Q1 us-gaap Share Price
SharePrice
1.50
CY2017Q1 us-gaap Share Price
SharePrice
1.50
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
216000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y6M7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M21D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y5M9D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
53000 shares
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
11988000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
20955000 USD
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67415000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62893000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79799000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74327000 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risk</font></div><div style="line-height:120%;text-align:left;padding-left:14px;text-indent:-14px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's accounts receivable are denominated in U.S. dollars and are derived primarily from sales to customers located in North America, Asia Pacific, and Europe. The Company performs ongoing credit evaluations of its customers and generally does not require collateral. See Note 11 for information regarding concentrations associated with accounts receivable.</font></div></div>
us-gaap Fiscal Period
FiscalPeriod
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">QuickLogic's fiscal year ends on the Sunday closest to December&#160;31 and the fiscal quarters each end on the Sunday closest to the end of each calendar quarter. QuickLogic's </font><font style="font-family:inherit;font-size:10pt;">second</font><font style="font-family:inherit;font-size:10pt;"> fiscal quarters for </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and for </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;"> ended on Sunday, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">July&#160;2, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">July&#160;3, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Uses of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities and the reported amounts of revenue and expenses during the period. Actual results could differ materially from those estimates, particularly in relation to revenue recognition, the allowance for doubtful accounts, sales returns, valuation of investments, valuation of long-lived assets including mask sets, valuation of inventories including identification of excess quantities, market value and obsolescence, measurement of stock-based compensation awards, accounting for income taxes and estimating accrued liabilities.</font></div></div>

Files In Submission

Name View Source Status
0000882508-17-000033-index-headers.html Edgar Link pending
0000882508-17-000033-index.html Edgar Link pending
0000882508-17-000033.txt Edgar Link pending
0000882508-17-000033-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
quik-20170702.xml Edgar Link completed
quik-20170702.xsd Edgar Link pending
quik-20170702_cal.xml Edgar Link unprocessable
quik-20170702_def.xml Edgar Link unprocessable
quik-20170702_lab.xml Edgar Link unprocessable
quik-20170702_pre.xml Edgar Link unprocessable
quik_2017xq2x10q.htm Edgar Link pending
quik_2017xq2x10qex311.htm Edgar Link pending
quik_2017xq2x10qex312.htm Edgar Link pending
quik_2017xq2x10qex321.htm Edgar Link pending
quik_2017xq2x10qex322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending